Nvidia’s AI-Fueled Growth Eases Bubble Concerns Despite Stock Dip
Nvidia’s recent earnings report showed solid revenue growth, even if it didn’t fully meet the sky-high expectations set by Wall Street.
Lowe’s $8.8 Billion Power Play: Can Foundation Building Materials Reinforce Its Pro Ambitions?
Business & Market Movers
Breaking News
Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled “Low Glycemic Sugar Composition.”
Impact Biomedical Inc. (IBIO), in which DSS Inc.(NYSE American: DSS) has a significant investment, is thrilled to announce a milestone in its innovative Laetose™ technology platform. The U.S. Patent and Trademark Office (USPTO) has issued U.S. patent # 11,898,184, entitled “Low Glycemic Sugar Composition” developed within this platform.
Bruush Oral Care Inc. and Arrive Technology Inc. Announce Agreement and Plan of Merger
scdadmin·Dec 15, 2023
Deep Dive & Research
Healthcare & Biotech
Y-mAbs’ $412 Million Take-Private Offer From SERB Poised To Upset The Oncology Landscape
Y-mAbs Therapeutics stunned investors when SERB Pharmaceuticals announced an all-cash bid to take the company private at $8.60 per share, valuing the deal at approximately $412 million.
Eli Lilly’s Obesity Pill Could Be a Game-Changer — But Here’s Why Zepbound Already Has a Giant Lead
DexCom’s Bold Type 2 Bet Could Reshape The Glucose Monitoring Market—What It Means for Investors!
Eli Lilly’s $1.3 Billion Gene Editing Bet: What the Verve Deal Signals for the Future of Heart Disease!
BioNTech’s High-Stakes Leap Into Cancer: Inside The $1.25 Billion CureVac Deal & Its Oncology Ambitions
Join our newsletter
Read and share new perspectives on just about any topic. Everyone’s welcome.- 01Create a free account
- 02Write your story
Tech & Energy
Nvidia’s AI-Fueled Growth Eases Bubble Concerns Despite Stock Dip
Nvidia’s recent earnings report showed solid revenue growth, even if it didn’t fully meet the sky-high expectations set by Wall Street.
Intel’s Last Stand: Why The U.S. Government May Take A Stake In The Struggling Chip Giant
